Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Replimune Group Inc (REPL)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Replimune Group Inc (REPL)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Replimune Group, Inc. - Common Stock.

Comment Full text

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Renovaro Biosciences Inc. - Common Stock.

Comment Full text

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Revelation Biosciences, Inc. - Common Stock.

Comment Full text

Replimune Group Inc (REPL)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N.

Comment Full text

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: D.

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Dr. Reddy’s Laboratories Ltd (RDY)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 35
  • 0 comments

NYSE traded attribute type Financial_Status was changed. Previous value: -. New value: .

Comment Full text

Dr. Reddy’s Laboratories Ltd (RDY)

  • Technical Exchange News
  • Jan. 28, 2024, 23:24 UTC
  • 34
  • 0 comments

NYSE traded attribute type Security_Name was changed. Previous value: -. New value: Dr. Reddys Laboratories Ltd Common Stock.

Comment Full text
  • Previous
  • 900
  • 901
  • 902
  • 903
  • 904
  • Next

Search

News categories

  • Technical Exchange News(12073)
  • Event(5289)
  • SEC News(250783)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150139)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin